OUR ETHICAL STANDARDS Ethics and Compliance, Every Day Every day, we strive to live up to the expectations of patients, physicians, and ourselves, and to earn trust in our communities. We know the importance of this responsibility, and we take it seriously. Alexion’s Board of Directors and Executive Committee have established an Executive-level Ethics and Compliance program, led by our Chief Compliance Officer, Compliance Committee and Compliance Team. Alexion’s Compliance program is tailored to meet the standards set forth by the Office of Inspector General (OIG) for the U.S. Department of Health and Human Services in its 2003 Compliance Program Guidance for Pharmaceutical Manufacturers. Alexion’s Compliance & Ethics Hotline The Alexion Compliance & Ethics Hotline offers employees, business partners, customers, and members of the public the opportunity to ask questions and/or report concerns about any potential misconduct or unethical behavior by Alexion or affiliated parties. Questions or concerns may be submitted using several methods listed on Alexion.com/EthicsHotline. ETHICS HOTLINE Compliance & Ethics Hotline (U.S.): 1-833-409-1023 Alexion’s Compliance Program incorporates the seven fundamental elements of an effective compliance program as defined by the OIG: 1. Designated compliance officer and compliance committee 2. Implementing written policies and procedures 3. Effective training and education 4. Open lines of communication 5. Internal auditing and monitoring 6. Enforcement of standards through disciplinary guidelines 7. Prompt response to detected problems through corrective actions Anti-Corruption and Anti-Bribery Alexion has a zero tolerance policy towards bribery and corruption. We comply with the anti-corruption laws of every country in which we operate, including the U.S. Foreign Corrupt Practices Act and the U.K. Bribery Act. Vendor Code of Conduct Alexion and its subsidiaries are committed to conducting business in an ethical, legal, and socially responsible manner. We expect our vendors to share this commitment. DOWNLOAD CODE Transparency Requirements Alexion will make public any disclosures necessary to comply with transparency laws or regulations applicable to pharmaceutical manufacturers, including, but not limited to, National Physician Payment Transparency Program (“Open Payments”) in the United States and the Loi Bertrand Act (“Sunshine Act”) in France. These regulations have mandated increased transparency in interactions between healthcare providers and companies manufacturing health care products and/or medical devices. The intention of these requirements is to address potential conflicts of interest in the interactions between these companies and healthcare professionals. To comply with these regulations, Alexion reports certain payments or other transfers of value made in the course of our professional interactions with healthcare professionals and healthcare organizations where applicable. Click here to view our 2019 and 2020 Luxembourg Disclosure Reports. California Compliance Declaration Alexion is committed to establishing and maintaining a comprehensive and effective compliance program in accordance with California SB 1765 (California Business & Professions Code 119400, 119402), and the Office of Inspector General, U.S. Department of Health and Human Services, “Compliance Program Guidance for Pharmaceutical Manufacturers.” VIEW DECLARATION I don’t define myself as having a rare disease. It’s part of my life but it’s certainly not who I am.” CHELSEY LIVING WITH NMOSD HEAR HER STORY MEDICAL PROFESSIONALS THE RARE DISEASE COMMUNITY INVESTORS JOB SEEKERS Contact Us Legal Statement Privacy Notice Terms of Use Cookie Settings This website is intended only for residents of the United States. © 2021 Alexion Pharmaceuticals, Inc.